𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A dose response evaluation of delta-1-testololactone in advanced breast cancer

✍ Scribed by Herbert Volk; Robert H. Deupree; Ira S. Goldenberg; Ralph C. Wilde; Ralph A. Carabasi; George C. Escher

Publisher
John Wiley and Sons
Year
1974
Tongue
English
Weight
385 KB
Volume
33
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

High response rate with a lower dose of
High response rate with a lower dose of paclitaxel in combination with cisplatin in heavily pretreated patients with advanced breast carcinoma
✍ Abdel G. Maiche; Antti P. Jekunen; Jaana Kaleva-Kerola; Guillermo Blanco Sequeir πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 150 KB πŸ‘ 1 views

## BACKGROUND. Paclitaxel has been found to be efficacious in the treatment of breast carcinoma either when administered alone or in combination with other anticancer agents. Synergistic interaction between paclitaxel and cisplatin has been demonstrated in vitro. ## METHODS. Thirty-two patients w

Clinical trial of Ξ”1-testololactone (NSC
Clinical trial of Ξ”1-testololactone (NSC 23759), medroxy progesterone acetate (NSC 26386) and oxylone acetate (NSC 47438) in advanced female mammary cancer: A report of the cooperative breast cancer group
✍ Ira S. Goldenberg πŸ“‚ Article πŸ“… 1969 πŸ› John Wiley and Sons 🌐 English βš– 329 KB

A'-TESTOLOLACTONE (NSC 23759), MEDROXY PROGESTERONE ACETATE (NSC 26386) AND OXYLONE ACETATE (NSC 47438) I N ADVANCED FEMALE MAMMARY CANCER A Reil,ort of the Cooperative Byeast Cancer G ~u ~I REPORT PREPARED HY IRA S. GOI-DEKHERG, MD Three hundred and nineteen women with advanced and metastatic carci